ABUS

Arbutus Biopharma Corp (ABUS)

US
$ 2.88-4.16%

Price Chart

Key Statistics

Market Cap
$ 599.48M
P/E Ratio
0.00
Revenue (TTM)
$ 6.4M
Volume
1.21M
52W High
$ 4.72
52W Low
$ 2.71
Dividend Yield
0.00%
Beta
1.50

Technicals

50-Day MA
3.2776
200-Day MA
3.5649
52 Week High
4.725
52 Week Low
2.705

About ABUS

Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States. Its chronic Hepatitis B virus product pipeline compr.

Employees
44
Headquarters
Warminster, PA
CEO
Ms. Lindsay Androski J.D., M.B.A.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg